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2Abstract
Ribosome profiling has predicted thousands of short open reading frames (sORFs) in eukaryotic 
cells, but still suffers from substantial levels of noise. PRICE (https://github.com/erhard-lab/price) is 
a computational method modeling the experimental noise to accurately resolve overlapping sORFs 
and non-canonical translation initiation. We experimentally validated translation using MHC-I 
peptidomics  and saw that sORF-derived peptides efficiently enter the MHC-I presentation pathway
and thus constitute a substantial fraction of the antigen repertoire.
Main
Ribosome profiling (Ribo-seq) is a powerful approach to measure translational activity in a genome-
wide and quantitative manner with base-pair resolution1. It visualizes the triplet shifts of actively 
translating ribosomes and thereby allows the identification of codons and their corresponding ORFs
translated at the time of cell lysis. This has resulted in the prediction of thousands of short open 
reading frames (sORFs) including upstream and upstream-overlapping ORFs (uORFs/uoORFs)
revealing an important new layer of translational control in eukaryotic cells2. However, accurate and 
reliable identification of sORFs has remained difficult for overlapping ORFs and for initiation at non-
canonical (non-AUG) start codons. In addition, the vast majority of these novel cryptic gene 
products have remained virtually undetectable in whole cellular proteomes and thus appear to be 
highly unstable. Here, we present a computational approach that enables accurate identification of 
sORFs in Ribo-seq data. It is based on computational modeling and subsequent removal of 
experimental noise from Ribo-seq data, allowing for improved statistical testing for active 
translation. Based on the accurate identification of thousands of sORFs, we show that, albeit being 
dramatically underrepresented in the cellular proteome, sORF-derived peptides efficiently enter the 
MHC-I presentation pathway and can be quantitatively recovered by MHC-I peptidome analysis. 
MHC-I peptidome analysis thus represents a potent method for large-scale validation of sORF 
3translation.
Ribosome footprints do not exhibit a singular specific size. Instead, reads are the result of two 
stochastic RNase cleavage events. Thus, deterministic rules (e.g. use an offset of 12) to recover the 
codon located in the P site of the actively translating ribosome (signal) lead to reads mapped to off-
frame codons (noise). Depending on the combination of read lengths used for charting ribosome 
occupancy, signal is traded off for the signal to noise ratio. Moreover, untemplated nucleotide 
additions frequently observed in Ribo-seq experiments further increase noise levels (see 
Supplementary Fig. 1).
We developed Probabilistic inference of codon activities by an EM algorithm (PRICE) to model the 
stochastic processes involved in Ribo-seq (Fig. 1a). For each individual experiment all parameters 
are directly inferred from annotated, well-translated ORFs. Any codon located in the P site of a 
ribosome is able to produce several kinds of footprints and their proportions depend on these 
parameters. Our method determines the set of codons that generates the observed reads with 
maximum likelihood (Supplementary Fig. 2). 
After assembling identified codons to ORF candidates, potential start codons are predicted with high 
accuracy using a machine-learning model (Supplementary Fig. 3). If available, this can also 
integrate samples treated with Lactimidomycin or Harringtonine for translation start site 
enrichment3,4. In principle, experimental noise in an ORF candidate can arise due to (i) reads from 
overlapping ORFs, (ii) ribosome scanning or abortive translation events in the leader sequence, or 
(iii) due to non-ribosome-mediated mRNA protection from RNase treatment. To exclude candidate 
ORFs that reflect experimental noise, we use a hypothesis test based on the generalized binomial 
distribution that is specifically designed to also identify overlapping ORFs (Fig. 1a).
We first compared the signal and noise levels obtained by PRICE to the deterministic codon mapping 
approaches utilized by prior methods5–11 (While this manuscript was under review, a further method
4for Ribo-seq data has been published12; however, it also utilizes the deterministic mapping strategy 
and does not address potentially overlapping ORFs). For Ribo-seq data obtained from herpes 
simplex virus 1 (HSV-1) infected primary human fibroblasts13, about 18 million of the 37 million 
reads mapping to CDS (49.1%) could be used for further analyses with the optimal deterministic 
mapping method (Supplementary Fig. 4). In contrast, applying PRICE allowed us to utilize more 
than 94% of the CDS mapped reads as signal and increased the signal-to-noise ratio from 6.3 to 
more than 18 (Fig. 1b). Similar improvements were achieved when reanalyzing various published 
Ribo-seq data from other labs (Supplementary Fig. 5). This included data from different organisms 
and experimental systems (Supplementary Table 1), which all strongly benefitted in signal-to-noise 
ratios and the total amount of usable reads.
We next assessed the reproducibility of different kinds of sORFs in two Ribo-seq experiments13,14. 
The performance of PRICE was compared with 6 previously published Ribo-seq analysis 
methods6–11. Only PRICE was able to reproducibly identify uORFs/uoORFs with the expected 
distribution of start codons. In addition, it was the only method able to reliably identify many 
uORFs/uoORFs with both canonical AUG initiation and non-canonical start codons 
(Supplementary Fig. 6 and 7). Of note, PRICE was >30-50 fold faster than the other method in 
analyzing both data sets (Supplementary Table 2), enabling Ribo-seq data analysis without special 
hardware.
To experimentally assess the sensitivity and specificity of our new approach, we prepared a database 
containing all ORFs identified by PRICE, ORF-RATER and Rp-Bp in primary human fibroblasts for 
validation by mass spectrometry. The number of peptides, which originated from the sORFs in our 
database still remained substantially underrepresented in a large published set of whole cell proteome 
data from primary human fibroblasts15  (Fig. 1c; Supplementary Table 3). Their detection did not 
exceed the false-discovery rate (FDR) of 1% used for peptide identification, which effectively 
5renders this kind of whole proteome mass-spec data useless for the validation of sORF expression
(Supplementary Fig. 8). 
Peptide presentation by MHC-I is thought to mainly depend on translation rates rather than overall 
protein abundance16. We thus screened a published (called data set 1) and a newly obtained MHC-I 
peptidome data set (called data set 2) from primary human fibroblasts17 with our database. While 
peptides identified based on the sORFs predicted by ORF-RATER and Rp-Bp again did not 
significantly exceed the FDR, the sensitivity of PRICE was substantially higher (2x and 4x compared 
to ORF-RATER and Rp-Bp, respectively; Fig. 1c) and significantly exceeded the FDR. Of note, 
almost all of the validated ORFs identified by ORF-RATER and Rp-Bp were also identified by 
PRICE confirming its high sensitivity.
To assess the specificity of sORFs identification, we compared the percentage of validated peptides 
among all possible peptides from identified ORFs with their respective translation rates obtained by 
Ribo-seq. For large annotated ORFs, the number of validated peptides in both the whole proteome 
(Supplementary Fig. 8b) and the MHC-I peptidome (Fig. 1d) increased with stronger translation. 
In the MHC-I peptidome, validation rates for sORFs identified by PRICE (but not any of the other 
algorithms) accounted for up to one third of the validation rate of large proteins (Fig. 1d) in two 
independent experiments (Supplementary Fig. 9). Therefore, sORFs-derived peptides are efficiently 
presented by MHC-I in a translation rate- but not abundance-dependent manner. Of note, similar to 
the MHC-I-associated peptides originating from the annotated cellular proteins, sORF-derived 
peptides showed high predicted binding affinities18 to the HLA allotypes (Supplementary Fig. 10). 
Incorporation of sORF-derived peptides into MHC-I thus appears to follow the same rules as 
observed for large ORFs and provides compelling evidence that the bulk of these cryptic gene 
products do not represent artifacts of Ribo-seq experiments. Interestingly, MHC-I presentation is 
thought to predominantly arise from so-called ‘defective ribosomal products’ (DRiPs), which are 
rapidly degraded upon translation by the proteasome16. Our findings highlight striking similarities of 
6DRiPs and sORFs suggesting that efficient targeting of sORF-derived proteins/peptides into the 
DRiPs pathway may contribute to their low abundance within the cellular proteome.
We used our validated approach to refine the annotation of the HCMV translatome14. In contrast to 
the original analysis of the Ribo-seq data (157 of 168 ORFs), PRICE recovered all 168 ORFs of the 
reference annotation. Furthermore, we confirmed more than half (248/480) of the novel ORFs 
identified in Ref. 14 and identified an additional 528 putative ORFs that were previously not detected 
(Fig. 2a). Of the 232 novel ORFs not recovered by PRICE, 141 were identified as noise, the 
remaining 91 did not show a clear signature of active translation (Supplementary Fig. 11a). The 
start codon distributions of the different sets of putative ORFs clearly show that majority of PRICE 
identified ORFs but not the ORFs discarded by PRICE indeed result from actively translating 
ribosomes (Fig. 2b-c).
It is important to note that, albeit showing a clear signature of active translation, about two-thirds of 
the 528 novel ORFs were expressed at low levels (Supplementary Fig. 11b). The functional role of 
many of these novel ORFs is therefore questionable. We also identified numerous novel large ORFs 
(>100aa) with low translation rates (Supplementary Fig. 11b). This is indicative of negative 
selection against the introduction of stop codons in the HCMV genome and strongly suggests that 
these indeed are, or once have been functional in the evolution of the virus.
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9Figure legends
Figure 1: The PRICE approach. 
Schematic of the approach. Left: Bars represent parameters of the probabilistic model. (a)
Center: Translated codons are identified by solving the inverse problem of the model. 
Right: calling actively translated ORFs based on the generalized binomial distribution (for 
details see Online Methods).
Approaches to map reads to codons are compared with respect to signal (total number of (b)
reads mapped in-frame) and the signal to noise ratio (noise: reads mapped out-of-frame to 
annotated ORFs). Colors represent deterministic mapping of read classes defined by length 
and 5’ mismatch state (red, grey), of combinations of read classes (blue; Basic: ignoring 5’ 
mismatches; Extended: considering 5’ mismatches; Top 4: combining the best read classes; 
see also Supplementary Fig. 4) and probabilistic mapping by PRICE (green).
Total amount of peptides detected in proteome and MHC-I peptidome mass spectrometry (c)
experiments (MHC-I peptidome data set 1; see Supplementary Fig. 9a for the other 
experiment). The 1% peptide identification FDR is indicated. Grey bars show the peptides 
from ORFs also identified by ORF-RATER or Rp-Bp (for PRICE) or ORFs also identified 
by PRICE (for ORF-RATER and Rp-Bp). .
d) Validation rates of peptides from predicted ORFs with a minimal number of reads per 
codon (MHC-I peptidome data set 2; see Supplementary Fig. 9b for the other experiment).
Rates for all ORFs (solid lines) identified by the indicated methods and for ORFs predicted 
de-novo (dashed lines) are shown. 
Figure 2: Re-decoding human cytomegalovirus
Venn diagram comparing the indicated datasets. We merged N-terminal variants of ORFs (a)
ending at the same stop codon.
Comparison of the start codon distribution of 528 novel ORFs detected only by PRICE (light (b)
green) to the distribution of the 248 confirmed ORFs (turquois) (, Fisher's combined 
probability test based on indicated one-sided binomial tests). Note that an ORF may have 
more than one start codon.
The start codon distribution of the 232 not confirmed ORFs (blue) and confirmed ORFs (c)
(turquoise) (, Fisher's combined probability test based on indicated one-sided binomial tests) .
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Online Methods
Read mapping
All annotations used in this study are based on Ensembl 75. Reads were mapped using Bowtie 1.019
to rRNA, genomic and transcriptomic sequences. rRNA reads and reads mapping to the 
mitochondrial genome were discarded, transcriptomic alignments preferred over genomic alignments. 
All alignments were mapped to genomic coordinates. Ambiguous alignments (w.r.t. genomic 
coordinates) were resolved using an adapted RESCUE procedure20. Briefly, for each 
multimapping read, we assess the number of reads mapping uniquely and close to each 
potential mapping site. For clear-cut cases, reads are mapped to one of the potential sites 
(e.g. no other reads at the other potential sites), in all other cases, reads are mapped to 
all sites and fractional counts are used (see Supplementary Note 1).
Inference of model parameters
Reads uniquely mapping within coding sequences and not overlapping a start or stop codon were 
collected. We define the frame of a read as the position of the first annotated codon within the read. 
If a read mapped to more than one isoform in different frames, it was discarded. We counted the 
three frames for each read class characterized by read length and 5’ mismatch state, which are the 
sufficient statistics for our EM algorithm that determines the maximum likelihood parameters  of the 
following model (see Supplementary Note 2 for details):
 is the probability of an untemplated 5’ nucleotide addition,  and  are the cleavage probabilities at 
distance  from the P site codon.  is the set of all reads, and  are the potential codon positions in a 
read  according to the annotation.
Codon inference
11
Based on the inferred model parameters , activity values of all contained codons  are estimated for 
observed reads  within a chunk of the genome by maximizing the likelihood of the following model:
Here,  is the activity of codon , and  is the probability that a ribosome at codon  has generated read , 
which can be directly computed from  (see Supplementary Note 3 for details).
Regularization 
We use a greedy strategy to seek a sparse solution of codons: First, the maximum likelihood solution 
is identified by the EM algorithm (see Supplementary Note 3). Then, we check for each codon, 
starting from the weakest to the most active, whether the decrease in the log likelihood without this 
codon is smaller than a parameter , in which case the codon is removed.  can be specified by the 
user or determined automatically by simulating reads from the model with a specific amount of off-
frame reads and choosing  such that the off-frame reads are still recognized as such (in this study 
we used 10% off-frame reads).
Start codon prediction
First, annotated ORFs were sorted according to their mean activity (geometric mean after removing 
zero-activity codons). Then, in bins of 1000 ORFs, a logistic regression model was trained based on 
the annotated start codons (positive set) and five random positions within the ORF (negative set). 
For each ORF, activity values from each sample were transformed using the arcsine function for 
variance stabilization and divided by the maximal value, providing the features for regression. To 
incorporate the massive difference between the start codon and the codons upstream, we used the 
range-score (sum of activities of the 10 codons downstream of the start codon including the start 
codon, divided by the sum of activities of codons +/- 10 codons around the start codon) as an 
additional feature for regression. To predict start codons, the probability from the logistic regression 
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was computed for each codon in an ORF candidate and divided by the maximal probability. This was 
multiplied by a factor penalizing start codon candidates for which less than 60% of the total activity 
was downstream of the start codon (see Supplementary Fig. 12), providing the final score for start 
codon prediction. All codons admissible by their sequence (here, AUG and all codons with one 
mismatch to AUG), that exceeded a minimal score (here: 0.1), were considered as start codon 
candidates.
Generating ORF candidates
First, a set of transcripts from the annotation was determined that is sufficient to explain most of the 
active codons. In a greedy fashion, the transcript explaining most of the remaining (still unexplained) 
reads is added to this set and this procedure is stopped if there is no transcript having at least 5 
unexplained reads. Based on the sequence, ORF candidates are generated from each transcript and 
filtered based on minimal criteria indicative for active translation (ending at a stop codon, not having 
an in-frame stop-codon, at least 5 reads, at least 25% of the codons active). 
Candidate filtering
All generated ORF candidates are first filtered according to two criteria: First, the number of active 
codons must exceed a minimal number as inferred from annotated ORFs with similar translation 
strength. Specifically, a threshold for activity was computed as 10% of the geometric mean  of all 
codon activities (after removing zero activity codons) for all annotated ORFs. One smoothing spline 
was fit to the graph of  against the fraction of codons over this threshold for each annotated ORF 
(see Supplementary Fig. 13a-b), and one to  against the squared residuals from the first smoothing 
spline. For a specific ORF candidate with geometric mean  the minimal number of active codons was 
computed as the 5% quantile of the beta distribution with mean and variance obtained from the two 
splines. Second, ORFs where the total activity of the first five codons was much higher than the total 
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activity of subsequent codons were filtered as abortive translation events. Specifically, we computed 
the empirical distribution of log2 fold changes between the average activity of the first five codons 
and the average of subsequent codons for annotated ORFs. ORF candidates were filtered if their 
corresponding log2 fold change was less than the 1% quantile of the empirical distribution.
Generalized binomial test
To test for ORF candidates being due to noise, we again computed the number of codons exceeding 
10% of the geometric mean of codon activities. With no overlapping ORF the probability of a codon 
to be due to noise was estimated from the upstream, downstream and off-frame region and a p value 
was computed using the binomial distribution. Specifically, for a specific set of codons , we 
computed the number  of codons exceeding the 10% cut-off and estimate the noise probability as . 
The pseudocounts used here correspond to a beta prior distribution similar to the estimation of fold-
changes in RNA-seq experiments21. This provides a function , that maps any set of codons to a noise 
probability. The noise probability used for the binomial test is . For an ORF candidate o of length 
amino acids, the  contains the  codons from all three frames upstream of o with respect to transcript i 
().  contains the  codons from all three frames downstream of o, and  contains the  off-frame codons 
of o. With overlapping ORFs, the situation is a bit more complex for both the hypothesis test and the 
estimate of noise probabilities. First, if an ORF q overlaps with o, then the test also has to respect 
that a codon exceeding the chosen cut-off in o may be due to q. Thus, the binomial probability is , 
where  is the noise probability as before, and is computed by a similar approach as for the filter for 
the minimal number of active codons. Specifically, for all annotated ORFs, a smoothing spline is 
fitted to the graph of the geometric means of all non-zero codons activities against the fraction of 
codons exceeding the current cut-off for o, and  is value of this spline for the geometric mean of q 
(see Supplementary Fig. 13c-f). If q and o overlap only partly, or there are several overlapping 
ORFs, the binomial probability is not the same for each of the  codons of o.  Therefore, the p value is 
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computed using the generalized binomial distribution that allows  distinct success probabilities using 
an efficient algorithm22. Moreover, the function does not only count codons in  exceeding or not 
exceeding the cut-off, but respects ORFs giving rise to active codons in  when there are overlapping 
ORFs. Specifically, for each , the probability  of being explained by an overlapping ORF is 
computed as .  and  are the probabilities of the codon to be explained by an in-frame codon (, if 
there is an in-frame overlapping ORF), or by an off-frame codon (estimated from smoothing splines 
like ). The expected number of unexplained codons over the cut-off in  then is  where  is the total 
number of codons exceeding the cut-off and  is the probability mass function of the generalized 
binomial distribution with parameters . Likewise, the expected number of codons not exceeding the 
cut-off is . Thus, .
Isoform deconvolution
Due to alternative splicing, predicted ORFs may also overlap partly in-frame, i.e. there may be 
codons that are shared between two or more ORFs. This gives rise to the same problem existing in 
RNA-seq, where many observed reads could be generated by more than one isoform. Thus, this is a 
well studies problem23. PRICE uses a widely adopted EM algorithm to deconvolute the contributions 
of ORFs to such codons, which maximizes the following likelihood:
 is the set of all codons,  is the estimated amount of reads mapped to codon ,  is the set of ORFs,  an 
indicator whether ORF contains codon , and  the length of ORF  in codons. The parameter that is 
estimated with maximum likelihood by the EM are the , the probabilities of generating a ribosome 
footprint for ORF .
Comparative analysis
The HSV-1 Ribo-seq data set was of better quality (according to their signal-to-noise ratio, see Fig.
15
2e) than the HCMV data set. Therefore, we reasoned that the ratio of the number of ORFs, which 
were identified in the HCMV data set (called the test data set) and reproducibly identified in the 
HSV-1 data set (called the reference data set), to the number of ORFs, which were only identified in 
the HCMV data set, is a measure for the overall reproducibility of a Ribo-seq analysis method across 
laboratories. An ORF was assumed reproducible, if the ORF in the HSV-1 data set showed the same 
stop codon, and if both ORFs were consistent with respect to introns (i.e. no intronic base pair of 
one ORF was present in an exon of the other ORF). This prevented the analysis to over-emphasize 
the prediction of the correct start codon, which is difficult for all methods not utilizing Harringtonin 
or Lactimidomycin data. For the inner-laboratory comparison we used the better of the two HSV-1 
replicates as the reference data set and the other biological replicate as the test data set. All methods 
were used with default parameters and applied on the same bam files as PRICE, with the exception 
of Rp-Bp, which uses its own pipeline including read mapping. For Rp-Bp, we extracted all mapped 
reads from the respective bam files and re-appended the sequencing adapter. The Rp-Bp pipeline was 
then run on the corresponding fastq files. We allowed for “NTG” start codons and used the default 
cutoff for Bonferroni corrected p values (1%) to call ORFs. We ran ORF-RATER according to the 
manual, allowing for all start codons with at most one mismatch to ATG and, by default, used an 
80% cutoff on the posterior probability. RibORF is not able to infer ORFs by itself, but only to score 
a given set of ORFs. We therefore identified all potential uORFs and uoORFs starting from start 
codons with at most one mismatch to ATG according to Ensembl v75, and supplied a Genpred file 
containing all protein coding Ensembl ORFs and the potential uORFs and uoORFs. The same is true 
for SPECtre, that included the computation of FLOSS and ORFScore, where we had to supply 
custom annotation in GTF format. For RibORF, SPECtre, FLOSS and ORFScore, score cutoffs 
were chosen such that the number of uORFs+uoORFs was 1000 in the test data set. We used the 
same cutoff for the reference data set, respectively. The offset parameters that had to be supplied to 
RibORF and SPECtre were taken from the study describing the HCMV data4,14 and determined 
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according to the optimal deterministic strategy described above for the HSV-1 data. Furthermore, 
except for Fig. 4a, before determining the cutoff, we removed all ORFs with an in-frame ratio 
(number of reads mapped to in-frame codons divided by number of reads mapped out-of-frame but 
within the ORF) below 50%, as previously suggested5. 
Signal and noise
After mapping of reads to codons by any method, the signal is defined as the total number of reads 
mapping to in-frame codons of an annotated ORF (Ensembl 75). Noise is defined as the total number 
of reads mapping to annotated ORFs out-of-frame.
Statistical tests
The binomial tests for Fig. 2b-c were computed as follows: Let  be the number of ORFs starting 
with codon  identified by PRICE (or Stern-Ginossar et al.) and  the number of ORFs identified by 
both PRICE and Stern-Ginossar et al. Under the null hypothesis that there is no difference in codon 
distributions between ORFs identified by PRICE (or Stern-Ginossar et al.) only and by both,  is 
binomially distributed with parameters  and . The p value was computed by the pbinom function of 
R (version 3.3.2). The combined p values were computed using Fisher’s method by computing the 
cumulative distribution function of the  distribution with 20 degrees of freedom (2 times the number 
of p values) for  (where the  are the p values of the binomial tests for all relevant codons).
Mass spectrometry
For the MHC-I peptidome data set 2, HLA class I ligands were isolated from 1ml cell pellets of 
mock treated or HCMV-infected HF99-7 human foreskin fibroblasts (HF99-7, HLA-A*01:01, 
A*03:01, B*08:01, B*51:01, C*07:01, C*01:02) by standard immunoaffinity purification using the 
pan-HLA class I-specific mAb W6/32 as described previously24. Sample shares of 20% were 
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analyzed in technical triplicates by LC-MS/MS. Peptides were separated by nanoflow HPLC 
(RSLCnano, Thermo Fisher Scientific) using a 50 μm x 25 cm Acclaim PepMap C18 column 
(Thermo Fisher Scientific) and a linear gradient ranging from 2.4% to 32.0% acetonitrile over the 
course of 90 min. Eluted peptides were analyzed in an online-coupled Orbitrap Fusion Lumos mass 
spectrometer (Thermo Fisher Scientific) using a data dependent  “top speed” collision-induced 
dissociation fragmentation method.  FT MS2 spectra for 2+ and 3+ precursors of 400-650 m/z were 
acquired at 30k resolution with AGC target values of 70,000 and maximum injection times of 
150ms. Normalized collision energy was set to 35%, dynamic exclusion time was set to 7s. The 
published MHC-I peptidome data set was obtained from the PRIDE repository (PXD000394). The 
whole proteome data was the same as used in Ref. 15. All mass spectrometry data were analyzed 
using MaxQuant25 1.5.8.3 by using the same set of parameters as in Ref. 17 with the exception that 
we used a sequence database composed of the human proteome from Ensembl v75, the HCMV 
proteome (NC_006273) and translated ORFs identified by PRICE, Rp-Bp or ORF-RATER in any of 
the HSV-1 or HCMV data set. We considered only cellular ORFs and used a FDR of 1% using the 
target-decoy approach based on “reverted” proteins implemented in MaxQuant. 
Data availability statement.
The MHC-I peptidome data have been deposited to the ProteomeXchange Consortium via the 
PRIDE partner repository with the dataset identifier PXD007203.
Life Sciences Reporting Summary.
Further information on experimental design is available in the Life Sciences Reporting Summary.
Code availability statement.
Our software implementation is available under open source license (Apache 2.0) on github and 
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available via http://software.erhard-lab.de. Release version “Price 1.0.1” was used in this report.
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